EGFR and colorectal carcinoma: Chen et al. [122] demonstrated that in BRAFV600E CRC cell lines BRAF inhibitors upregulated the WNT/beta-catenin pathway through activating FAK independently of EGFR and MEK signaling [Figure 2].